Nitric oxide boosts TLR-4 mediated lipocalin 2 expression in chondrocytes

Journal of Orthopaedic Research

Volumn 31, Issue 7, 2013, Pages 1046-1052

  Gõmez, Rodolfo ^a   Scotece, Morena ^a   Conde, Javier ^a   Lopez, Veronica ^a   Pino, Jesus ^b   Lago, Francisca ^a   Gõmez Reino, Juan J ^a   Gualillo, Oreste ^a  

^a Santiago University Clinical Hospital   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

adipokines; chondrocyte; inflammation; LCN2; nitric oxide; TLR4

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NITRIC OXIDE; NITROPRUSSIDE SODIUM; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARTILAGE CELL; CELL VIABILITY; COLORIMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACUTE-PHASE PROTEINS; ANIMALS; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; CHONDROCYTES; GUANIDINES; LIPOCALINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; ONCOGENE PROTEINS; TOLL-LIKE RECEPTOR 4;

EID: 84878183175     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22331     Document Type: Article

References (44)

1. Kim HA, Cho ML, Choi HY, et al. 2006. The catabolic pathway mediated by toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum 54: 2152-2163. (Pubitemid 44051072)
2. Goldring MB, Marcu KB., 2009. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther 11: 224.
3. Chen K, Huang J, Gong W, et al. 2007. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 7: 1271-1285. (Pubitemid 47126372)
4. Pierer M, Wagner U, Rossol M, et al. 2011. Toll-like receptor 4 is involved in inflammatory and joint destructive pathways in collagen-induced arthritis in DBA1J mice. PLoS ONE 6: e23539.
5. Wang P, Zhu F, Tong Z, et al. 2011. Response of chondrocytes to shear stress: antagonistic effects of the binding partners toll-like receptor 4 and caveolin-1. FASEB J 25: 3401-3415.
6. Clancy RM, Gomez PF, Abramson SB., 2004. Nitric oxide sustains nuclear factor kappaB activation in cytokine-stimulated chondrocytes. Osteoarthritis Cartilage 12: 552-558. (Pubitemid 38950265)
7. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, et al. 2008. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 118: 205-216.
8. Conde J, Gomez R, Bianco G, et al. 2011. Expanding the adipokine network in cartilage: identification and regulation of novel factors in human and murine chondrocytes. Ann Rheum Dis 70: 551-559.
9. Otero M, Lago R, Gomez R, et al. 2007. Phosphatidylinositol 3-kinase, MEK-1 and p38 mediate leptin/interferon-gamma synergistic NOS type II induction in chondrocytes. Life Sci 81: 1452-1460. (Pubitemid 350018780)
10. Otero M, Lago R, Lago F, et al. 2005. Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Res Ther 7: R581-R591.
11. Abramson SB, Attur M, Amin AR, et al. 2001. Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 3: 535-541.
12. Pelletier JP, Mineau F, Ranger P, et al. 1996. The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 4: 77-84. (Pubitemid 26096758)
13. Stadler J, Stefanovic-Racic M, Billiar TR, et al. 1991. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 147: 3915-3920.
14. Denko CW, Malemud CJ., 1999. Metabolic disturbances and synovial joint responses in osteoarthritis. Front Biosci 4: D686-D693.
15. Martel-Pelletier J, Alaaeddine N, Pelletier JP., 1999. Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci 4: D694-D703.
16. Hayashi T, Abe E, Yamate T, et al. 1997. Nitric oxide production by superficial and deep articular chondrocytes. Arthritis Rheum 40: 261-269. (Pubitemid 27114089)
17. Wu GJ, Chen TG, Chang HC, et al. 2007. Nitric oxide from both exogenous and endogenous sources activates mitochondria-dependent events and induces insults to human chondrocytes. J Cell Biochem 101: 1520-1531.
18. Taskiran D, Stefanovic-Racic M, Georgescu H, et al. 1994. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Commun 200: 142-148.
19. Sasaki K, Hattori T, Fujisawa T, et al. 1998. Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes. J Biochem 123: 431-439. (Pubitemid 28143497)
20. Lago F, Dieguez C, Gomez-Reino JJG, et al. 2007. Adipokines as emerging mediators of immune response and inflammation. Nature clinical practice Rheumatology 3: 716-724. (Pubitemid 350187017)
21. Gõmez R, Conde J, Scotece M, et al. 2011. What's new in our understanding of the role of adipokines in rheumatic diseases? Nature Publishing Group. 1-9.
22. Gupta K, Shukla M, Cowland JB, et al. 2007. Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9. Arthritis Rheum 56: 3326-3335. (Pubitemid 47585427)
23. Devireddy LR, Gazin C, Zhu X, et al. 2005. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123: 1293-1305. (Pubitemid 41821786)
24. Hvidberg V, Jacobsen C, Strong RK, et al. 2005. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett 579: 773-777.
25. Yan QW, Yang Q, Mody N, et al. 2007. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56: 2533-2540. (Pubitemid 47523260)
26. Owen HC, Roberts SJ, Ahmed SF, et al. 2008. Dexamethasone-induced expression of the glucocorticoid response gene lipocalin 2 in chondrocytes. Am J Physiol Endocrinol Metab 294: E1023-E1034.
27. Ulivi V, Tutolo G, Mallein-Gerin F, et al. 2006. A common pathway in differentiation and inflammation: p38 mediates expression of the acute phase SIP24 iron binding lipocalin in chondrocytes. J Cell Physiol 206: 728-737. (Pubitemid 43191048)
28. Zerega B, Cermelli S, Michelis B, et al. 2000. Expression of NRL/NGAL (neu-related lipocalin/neutrophil gelatinase-associated lipocalin) during mammalian embryonic development and in inflammation. Eur J Cell Biol 79: 165-172. (Pubitemid 30179500)
29. Sommer G, Weise S, Kralisch S, et al. 2009. Lipocalin-2 is induced by interleukin-1beta in murine adipocytes in vitro. J Cell Biochem 106: 103-108.
30. Jiang W, Constante M, Santos MM., 2008. Anemia upregulates lipocalin 2 in the liver and serum. Blood Cells Mol Dis 41: 169-174.
31. Katano M, Okamoto K, Arito M, et al. 2009. Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis. Arthritis Res Ther 11: R3.
32. Wilson R, Belluoccio D, Little CB, et al. 2008. Proteomic characterization of mouse cartilage degradation in vitro. Arthritis Rheum 58: 3120-3131.
33. Flower DR., 1996. The lipocalin protein family: structure and function. Biochem J 318: 1-14. (Pubitemid 26283618)
34. Devireddy LR, Teodoro JG, Richard FA, et al. 2001. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293: 829-834. (Pubitemid 32743967)
35. Chu ST, Lin HJ, Huang HL, et al. 1998. The hydrophobic pocket of 24p3 protein from mouse uterine luminal fluid: fatty acid and retinol binding activity and predicted structural similarity to lipocalins. J Pept Res 52: 390-397.
36. Yang J, Goetz D, Li JY, et al. 2002. An iron delivery pathway mediated by a lipocalin. Mol Cell 10: 1045-1056. (Pubitemid 35453824)
37. Cowland JB, Borregaard N., 1997. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45: 17-23. (Pubitemid 27449379)
38. Goetz DH, Holmes MA, Borregaard N, et al. 2002. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10: 1033-1043. (Pubitemid 36001971)
39. Iacono A, Gomez R, Sperry J, et al. 2010. Effect of oleocanthal and its derivatives on inflammatory response induced by lipopolysaccharide in a murine chondrocyte cell line. Arthritis Rheum 62: 1675-1682.
40. Gomez R, Lago F, Gomez-Reino JJ, et al. 2009. Expression and modulation of ghrelin O-acyltransferase in cultured chondrocytes. Arthritis Rheum 60: 1704-1709.
41. von Knethen A, Callsen D, Brune B., 1999. NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol Biol Cell 10: 361-372. (Pubitemid 29156478)
42. Abdollahi-Roodsaz S, Joosten LA, Roelofs MF, et al. 2007. Inhibition of toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum 56: 2957-2967. (Pubitemid 47502742)
43. Sohn DH, Sokolove J, Sharpe O, et al. 2012. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via toll-like receptor 4. Arthritis Res Ther 14: R7.
44. Konttinen YT, Sillat T, Barreto G, et al. 2012. Osteoarthritis as an autoinflammatory disease caused by chondrocyte-mediated inflammatory responses. Arthritis Rheum 64: 613-616.